Point72 Asset Management
XERS icon

Point72 Asset Management’s Xeris Biopharma Holdings XERS Stock Holding History

Point72 Asset Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-608,080
Closed -$4.77M – 4929
2025
Q4 		$4.77M Buy
+608,080
New +$4.79M 0.01% 1881
2025
Q3 		– Sell
-45,100
Closed -$211K – 2966
2025
Q2 		$211K Sell
45,100
-43,273
-49% -$198K ﹤0.01% 1974
2025
Q1 		$485K Buy
+88,373
New +$357K ﹤0.01% 1638
2023
Q4 		– Sell
-655,000
Closed -$1.22M – 3053
2023
Q3 		$1.22M Buy
+655,000
New +$1.5M ﹤0.01% 1269
2023
Q1 		– Sell
-60,000
Closed -$79.8K – 2697
2022
Q4 		$79.8K Buy
+60,000
New +$84.7K ﹤0.01% 1317
2020
Q3 		– Sell
-232,410
Closed -$618K – 1146
2020
Q2 		$618K Buy
+232,410
New +$809K ﹤0.01% 701
2018
Q3 		– Sell
-5,000
Closed -$95K – 1298
2018
Q2 		$95K Buy
+5,000
New +$97.2K ﹤0.01% 933

Other funds holding XERS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $244M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return